Evidence map›Paper›PMID 18079549›Full record

ReviewBMJ (Clinical research ed.)2007

Cystic fibrosis.

Jane C Davies, Eric W F W Alton, Andrew Bush

Registry-linked trialAbstract readReview
In one paragraph

Review in BMJ (Clinical research ed.), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02262871 (Randomized Cross-over Physiologic Study of High Flow Nasal Oxygen Cannula Versus Non-invasive Ventilation in Cystic Fibrosis. The HIFEN Study), which is not on this map. Cited by 125 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02262871 nacompletednot on this mapstarted 2014, after this paper: background citation

Randomized Cross-over Physiologic Study of High Flow Nasal Oxygen Cannula Versus Non-invasive Ventilation in Cystic Fibrosis. The HIFEN Study

TypeinterventionalSponsorUnity Health TorontoRan2014 to 2017Enrolled15ConditionsCystic FibrosisArmsHigh flow nasal oxygen cannula, Noninvasive ventilation
3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis.European respiratory review : an official journal of the European Respiratory Society · 2013
    Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Recent advances in smart contact lenses.Biosensors & bioelectronics: X · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Effect of Elexacaftor/Tezacaftor/Ivacaftor onThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2024
    Article
  14. Polymicrobial interactions influenceFrontiers in microbiology · 2024
    Article
  15. Article
  16. Article
  17. COVID-19 in a Cystic Fibrosis Patient.Oman medical journal · 2023
    Article
  18. Article
  19. Article
  20. AIMS microbiology · 2023
    Review

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jane C DaviesDepartment of Gene Therapy, Imperial College, London. j.c.davies@ic.ac.uk
Eric W F W Alton
Andrew Bush

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cystic FibrosisCost of IllnessCystic Fibrosis Transmembrane Conductance RegulatorElectrolytesHumansMass ScreeningSweatCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorElectrolytes

Identifiers

PMID18079549
PMCPMC2137053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.